Delivery Order SPE2DB20D2104-SPE2DB22FT36W
Award Date 7/22/22
Potential Completion Date 7/25/22
Potential Value $3.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,790.11 firm fixed-price delivery order is for the supply of XYLOCAINE-MPF 2% 40 MG/2 ML VL 2ML, a pharmaceutical product, with a period of performance ending on October 31, 2024. The award is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
- This federal contract award, with ID SPE2DX15D1104|SPE2DX24F3FH9, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $1,037.22 firm fixed-price delivery order is for the pharmaceutical product XYLOCAINE-MPF 2% VIAL 5ML, with an ultimate completion date of October 27, 2023. This award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
- This federal contract award is for the delivery of Xylocaine-MPF 2% 40 mg/2 ml vials to the Defense Logistics Agency (DLA). The contract, valued at $6,221.86, was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is March 18, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider...
- This federal contract award, valued at $3,731.66, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of XYLOCAINE-MPF 2% AMPUL 10ML, a medical product. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division. The $3,056.94 firm fixed-price delivery order is for the supply of XYLOCAINE-MPF 1% VIAL 5ML, a local anesthetic medication, with a completion date of June 13, 2024. This award is a task order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA, which serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,431.84 Firm Fixed Price Delivery Order is for the supply of XYLOCAINE 1%-EPI 1:100,000 20ML, a medical product used for anesthesia. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract, valued at $1,179.40, is for the delivery of pharmaceutical products, specifically XYLOCAINE-MPF 1%-EPI 1:200,000 30ML, to support various government agencies and healthcare programs. The contract is a firm fixed-price Delivery Order, with a period of performance running through September 2024. Amerisourcebergen, a major supplier of...
- This contract award is for the delivery of XYLOCAINE 2%-EPI 1:200,000 20ML to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The award, valued at $1,249.07, was made to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. As a subsidiary of Amerisourcebergen Corporation, the awardee leverages its parent company's extensive supply chain network to fulfill government contracts. The contract has a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply XYLOCAINE-MPF 2% 100 MG/5 ML 5ML pharmaceuticals. The $1,742.00 delivery order has a completion date of January 11, 2024. Amerisourcebergen Drug Corp, as a prime contractor, provides a range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities to support military treatment programs. The...
- This is a federal contract award issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, identified as SPE2DB20D3103/SPE2DB24FM0T3, is a Delivery Order with a Firm Fixed Price pricing type and a ceiling value of $2,004.96. It covers the supply of XYLOCAINE-MPF 2% 40 MG/2 ML VL 2ML, a pharmaceutical product. The award is not designated under any set-aside program. Amerisourcebergen Drug Corp...